CCL5 and neoplasm: To evaluate the dynamic reversible process of TME regulation by TILs and chemokines, we enrolled 20 paired ccRCC and normal tissues from the FUSCC cohort and performed IHC staining analysis to assess the protein expression of CCL5 in the tumor, stromal, and normal samples (Figure 1A).